tarceva (drug)

literal strings: Tarceva, TARCEVA, tarceva

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• tarceva is a drug     
• tarceva is an archaeon     
• tarceva is a drug having the side effect side_effects (disease)     
• tarceva is a drug that might treat cancer (disease)     
• tarceva is a drug worked on by genentech (biotechcompany)     
• tarceva is a drug worked on by osi (biotechcompany)     

categories

• drug(100.0%)
• MBL @310 (100.0%) on 22-jun-2011 [ Promotion of archaea:tarceva drugworkedonbyagent biotechcompany:genentech ]
• SEAL @202 (98.4%) on 09-feb-2011 [ 1 2 3 4 5 6 ] using tarceva
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of archaea:tarceva drugworkedonbyagent biotechcompany:roche ] using concept:archaea:tarceva
• product(100.0%)
• CPL @1104 (87.8%) on 18-mar-2018 [ "Medical Information links for _" "DDD-mg dose of _" "cancer drug called _" "_ is a targeted therapy" "full prescribing information on _" "newer drugs such as _" "nursing infants from _" "side effects are possible with _" "newer drugs like _" "_ is the only drug" "drugs like _" "drug treatments like _" "chemotherapy drug called _" "_ read the NOTE." "_ is a prescription drug" "generic drug name for _" "cancer drugs like _" "common side effects with _" "_ is the first drug" "patent protection provided to _" "new drugs like _" "drugs , such as _" "pills such as _" "Clinical Results FDA approval of _" "prescription drug , such as _" "new drug called _" "drugs such as _" "cancer drugs such as _" "trials possibly related to _" "_ is a wonderful drug" "clinical trials possibly related to _" "_ inhibits an enzyme" "_ is an RX drug available" "Well-designed clinical trials related to _" "effects are possible with _" "medications such as _" "levels/effects of _" "Drug Interactions with _" "Well-designed clinical trials possibly related to _" "inhibitor like _" "Pills such as _" "_ is an oral drug" "prescription drugs like _" "other drugs , such as _" "_ regarding intake guidelines" "_ is a chemotherapy drug" "Results FDA approval of _" "pill called _" "inhibitor such as _" "certain drugs , including _" "essential prescription drugs like _" ] using tarceva
• OE @842 (94.8%) on 29-may-2014 [ http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000618/human_med_001077.jsp&mid=WC0b01ac058001d124 http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000618/human_med_001077.jsp&mid=WC0b01ac058001d124 http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000618/human_med_001077.jsp&mid=WC0b01ac058001d124 http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/22/tarceva-battles-lung-cancer-in-some http://chemocare.com/chemotherapy/drug-info/Tarceva.aspx http://www.drugdevelopment-technology.com/projects/tarceva/ http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000618/human_med_001077.jsp&mid=WC0b01ac058001d124 http://www.gene.com/patients/medicines/tarceva http://www.cancer.gov/cancertopics/druginfo/fda-erlotinib-hydrochloride http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/22/tarceva-battles-lung-cancer-in-some http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://parade.condenast.com/55792/jenniferglass/at-the-top-of-my-lungs-tarceva-diva/ http://chemocare.com/chemotherapy/drug-info/Tarceva.aspx http://www.drugs.com/tarceva.html http://www.medicines.org.uk/emc/medicine/16781/SPC/Tarceva+25mg,+100mg+and+150mg+Film-Coated+Tablets/ http://www.ema.  ] using tarceva
• SEAL @111 (99.2%) on 02-jun-2010 [ 1 2 3 4 5 6 7 ] using tarceva
• archaea(97.1%)
• CPL @1103 (97.1%) on 08-mar-2018 [ "inhibitor like _" "side effects of _" "side effects with _" "dosage of _" "FDA approves _" "drug , called _" "clinical trial of _" "common side effects with _" "you are taking _" "treatment with _" "side effects from _" "drug called _" "concurrent administration of _" "Side effects from _" "inhibitors such as _" ] using tarceva

relations

• drughassideeffect
• side_effects (disease) (100.0%)
• SEAL @523 (100.0%) on 02-mar-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using (tarceva, side_effects)
• CPL @1103 (75.0%) on 06-mar-2018 [ "arg1 generally produce fewer arg2" "arg1 to monitor progress and arg2" ] using (tarceva, side_effects)
• OE @809 (100.0%) on 01-feb-2014 [   ] using (tarceva, side_effects)
• drugpossiblytreatsphysiologicalcondition
• cancer (disease) (100.0%)
• SEAL @667 (100.0%) on 08-dec-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ] using (tarceva, cancer)
• OE @802 (99.6%) on 09-jan-2014 [   ] using (tarceva, cancer)
• drugworkedonbyagent
• genentech (biotechcompany) (100.0%)
• SEAL @331 (100.0%) on 03-jul-2011 [ 1 ] using (tarceva, genentech)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 is marketed by arg2" ] using (tarceva, genentech)
• osi (biotechcompany) (100.0%)
• OE @806 (85.3%) on 23-jan-2014 [   ] using (tarceva, osi)
• SEAL @236 (100.0%) on 16-apr-2011 [ 1 ] using (tarceva, osi)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 was discovered and developed by arg2" ] using (tarceva, osi)
• roche (company) (100.0%)
• SEAL @263 (100.0%) on 22-may-2011 [ 1 2 3 4 5 ] using (tarceva, roche)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 under the tradename arg1" ] using (tarceva, roche)

NELL has only weak evidence for items listed in grey

• drugpossiblytreatsphysiologicalcondition
• non_small_cell_lung_cancer (disease)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg2 and was treated with arg1" ] using (tarceva, non_small_cell_lung_cancer)
• drugworkedonbyagent
• osi_pharmaceuticals
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (tarceva, osi_pharmaceuticals_inc_)
• SEAL @331 (50.0%) on 03-jul-2011 [ 1 ] using (tarceva, osi_pharmaceuticals)
• roche_laboratories
• SEAL @691 (50.0%) on 29-jan-2013 [ 1 2 ] using (tarceva, roche_laboratories)
• drughassideeffect
• side_effects (bacteria)
• SEAL @523 (100.0%) on 02-mar-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using (tarceva, side_effects)
• CPL @1103 (75.0%) on 06-mar-2018 [ "arg1 generally produce fewer arg2" "arg1 to monitor progress and arg2" ] using (tarceva, side_effects)
• OE @809 (100.0%) on 01-feb-2014 [   ] using (tarceva, side_effects)
• events (bakedgood)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (beverage)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (building)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (celltype)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (chemical)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (cognitiveactions)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (condiment)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (date)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• deaths (eventoutcome)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg2 in patients taking arg1" ] using (tarceva, deaths)
• events (eventoutcome)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (female)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (geometricshape)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (hobby)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• combination_therapy
• CPL @1103 (50.0%) on 06-mar-2018 [ "arg1 and Celebrex arg2" ] using (tarceva, combination_therapy)
• events (medicalprocedure)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (mlarea)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (musicalbum)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• deaths (newspaper)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg2 in patients taking arg1" ] using (tarceva, deaths)
• events (park)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• deaths (politicsblog)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg2 in patients taking arg1" ] using (tarceva, deaths)
• events (politicsissue)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• deaths (profession)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg2 in patients taking arg1" ] using (tarceva, deaths)
• events (profession)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (stateorprovince)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (televisionshow)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (tradeunion)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (visualartist)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• events (visualizablescene)
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg2 in patients taking arg1" ] using (tarceva, events)
• drugpossiblytreatsphysiologicalcondition
• non_small_cell_lung_cancer (biotechcompany)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg2 and was treated with arg1" ] using (tarceva, non_small_cell_lung_cancer)
• cancer (medicalprocedure)
• SEAL @667 (100.0%) on 08-dec-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ] using (tarceva, cancer)
• OE @802 (99.6%) on 09-jan-2014 [   ] using (tarceva, cancer)
• drugworkedonbyagent
• osi (automobilemaker)
• OE @806 (85.3%) on 23-jan-2014 [   ] using (tarceva, osi)
• SEAL @236 (100.0%) on 16-apr-2011 [ 1 ] using (tarceva, osi)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 was discovered and developed by arg2" ] using (tarceva, osi)
• osi_pharm
• SEAL @527 (50.0%) on 08-mar-2012 [ 1 ] using (tarceva, osi_pharm)
• genentech (magazine)
• SEAL @331 (100.0%) on 03-jul-2011 [ 1 ] using (tarceva, genentech)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 is marketed by arg2" ] using (tarceva, genentech)
• osi (musicalbum)
• OE @806 (85.3%) on 23-jan-2014 [   ] using (tarceva, osi)
• SEAL @236 (100.0%) on 16-apr-2011 [ 1 ] using (tarceva, osi)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 was discovered and developed by arg2" ] using (tarceva, osi)
• osi (musicartist)
• OE @806 (85.3%) on 23-jan-2014 [   ] using (tarceva, osi)
• SEAL @236 (100.0%) on 16-apr-2011 [ 1 ] using (tarceva, osi)
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 was discovered and developed by arg2" ] using (tarceva, osi)
• roche (winery)
• SEAL @263 (100.0%) on 22-may-2011 [ 1 2 3 4 5 ] using (tarceva, roche)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 under the tradename arg1" ] using (tarceva, roche)